Radiological Reporting Systems in Multiple Sclerosis

(1) Background: Although MRI is a well-established tool in Multiple Sclerosis (MS) diagnosis and management, neuroradiological reports often lack standardization and/or quantitative information, with possible consequences in clinical care. The aim of this study was to evaluate the impact of informat...

Full description

Saved in:
Bibliographic Details
Published in:Applied sciences 2024-07, Vol.14 (13), p.5626
Main Authors: Scaravilli, Alessandra, Tranfa, Mario, Pontillo, Giuseppe, Carotenuto, Antonio, Lapucci, Caterina, Nistri, Riccardo, Signoriello, Elisabetta, Moccia, Marcello, Tortorella, Carla, Capra, Ruggero, Lus, Giacomo, Inglese, Matilde, Gasperini, Claudio, Lanzillo, Roberta, Pozzilli, Carlo, Brescia Morra, Vincenzo, Brunetti, Arturo, Petracca, Maria, Cocozza, Sirio
Format: Article
Language:English
Subjects:
Atrophy
Biomarkers
Clinical medicine
Decision making
Medical imaging
Multiple sclerosis
quantitative software
Questionnaires
Software
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:(1) Background: Although MRI is a well-established tool in Multiple Sclerosis (MS) diagnosis and management, neuroradiological reports often lack standardization and/or quantitative information, with possible consequences in clinical care. The aim of this study was to evaluate the impact of information provided by neuroradiological reports and different reporting systems on the clinical management of MS patients. (2) Methods: An online questionnaire was proposed to neurologists working in Italian tertiary care level MS centers. Questions assessed the impact of different MRI-derived biomarkers on clinical choices, the preferred way of receiving radiological information, and the neurologists’ opinions about different reporting systems and the use of automated software in clinical practice. (3) Results: The online survey was completed by 62 neurologists. New/enlarging (100%) lesions, the global T2w/FLAIR lesion load (96.8%), and contrast-enhancing (95.2%) lesions were considered the most important biomarkers for therapeutic decision, while new/enlarging lesions (98.4%), global T2w/FLAIR lesion load (96.8%), and cerebral atrophy (90.3%) were relevant to prognostic evaluations. Almost all participants (98.4%) considered software for medical imaging quantification helpful in clinical management, mostly in relation to prognostic evaluations. (4) Conclusions: These data highlight the impact of providing accurate and reliable data in neuroradiological reports. The use of software for medical imaging quantification in MS can be helpful to standardize radiological reports and to provide useful clinical information to neurologists.
ISSN:2076-3417
2076-3417
DOI:10.3390/app14135626